JP2024520701A5 - - Google Patents

Info

Publication number
JP2024520701A5
JP2024520701A5 JP2023574610A JP2023574610A JP2024520701A5 JP 2024520701 A5 JP2024520701 A5 JP 2024520701A5 JP 2023574610 A JP2023574610 A JP 2023574610A JP 2023574610 A JP2023574610 A JP 2023574610A JP 2024520701 A5 JP2024520701 A5 JP 2024520701A5
Authority
JP
Japan
Prior art keywords
methyl
ethyl
alcohol
complex
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023574610A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520701A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031777 external-priority patent/WO2022256412A2/en
Publication of JP2024520701A publication Critical patent/JP2024520701A/ja
Publication of JP2024520701A5 publication Critical patent/JP2024520701A5/ja
Pending legal-status Critical Current

Links

JP2023574610A 2021-06-01 2022-06-01 眼科薬の長期放出薬物送達システムおよび使用方法 Pending JP2024520701A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163195697P 2021-06-01 2021-06-01
US63/195,697 2021-06-01
US202163281052P 2021-11-18 2021-11-18
US63/281,052 2021-11-18
PCT/US2022/031777 WO2022256412A2 (en) 2021-06-01 2022-06-01 Extended release drug delivery system for ocular drugs and methods of use

Publications (2)

Publication Number Publication Date
JP2024520701A JP2024520701A (ja) 2024-05-24
JP2024520701A5 true JP2024520701A5 (cg-RX-API-DMAC7.html) 2025-05-22

Family

ID=84324518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023574610A Pending JP2024520701A (ja) 2021-06-01 2022-06-01 眼科薬の長期放出薬物送達システムおよび使用方法

Country Status (10)

Country Link
US (1) US20240269320A1 (cg-RX-API-DMAC7.html)
EP (1) EP4351612A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024520701A (cg-RX-API-DMAC7.html)
KR (1) KR20240039092A (cg-RX-API-DMAC7.html)
CN (1) CN121465998A (cg-RX-API-DMAC7.html)
AU (1) AU2022286942A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023025185A2 (cg-RX-API-DMAC7.html)
CA (1) CA3221045A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023014380A (cg-RX-API-DMAC7.html)
WO (1) WO2022256412A2 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2951014A (en) * 1957-01-03 1960-08-30 Upjohn Co Process for a stable oil suspension
PT1511516E (pt) * 2002-05-28 2009-02-20 Nycomed Gmbh Preparação farmacêutica para aplicação tópica
WO2004004682A2 (en) * 2002-07-02 2004-01-15 Laboratorios S.A.L.V.A.T., S.A. Stable oily suspension of microgranules
US9427423B2 (en) * 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
WO2007122624A2 (en) * 2006-04-24 2007-11-01 Technion Research And Development Foundation Ltd. Non-covalent complexes of bioactive agents with starch for oral delivery
RU2017105844A (ru) * 2014-08-08 2018-09-11 Форсайт Вижн4, Инк. Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
WO2016057809A1 (en) * 2014-10-10 2016-04-14 Therakine Mg stearate - based composite nanoparticles, methods of preparation and applications

Similar Documents

Publication Publication Date Title
JP2683575B2 (ja) 固体状脂質微粒子(固体状脂質ナノ球体)製の薬剤用キャリヤー
TWI732773B (zh) 用於奈米顆粒冷凍乾燥形式的組成物及方法
EP0860166B1 (en) Nanoparticles based on hydrophilic polymers as pharmaceutical forms
JP2002500165A (ja) 新規の重合性の脂肪酸、リン脂質、及びそれから得られた重合リポソーム
JP2012513456A (ja) 少なくとも1種のモノクローナル抗体及び疎水性置換基を有する少なくとも1種の両親媒性多糖類を含有する安定な医薬組成物
EP1525246A2 (fr) Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
CN103619325A (zh) 用于生产脂质体的方法
CN108685873B (zh) 仿生型自组装球形核酸纳米颗粒及其制备方法与用途
KR102190157B1 (ko) 표적화된 기체-충전 미세소포 제형
JPH06508610A (ja) 医薬組成物
JP2005535604A (ja) 治療剤を含むポリマーナノ物品
Bondioli et al. Sialic acid as a potential approach for the protection and targeting of nanocarriers
JP2024520701A5 (cg-RX-API-DMAC7.html)
JP5787323B2 (ja) 脂質膜構造体
BE1024228B1 (fr) Nouvelles formulations d'adjuvants
MXPA06010950A (es) Formulaciones en nano-particulas de compuestos de platino.
Roy et al. Biomedical Applications of Pullulan
JP2024521373A (ja) 硝子体内ミトコンドリア標的化ペプチドプロドラッグおよび使用方法
US20240269320A1 (en) Extended release drug delivery system for ocular drugs and methods of use
CN117881411A (zh) 用于眼部药物的延长释放药物递送系统和使用方法
Katarija et al. The review of patents on solid lipid nanoparticles
WO2013045729A1 (es) Nanogeles de ciclodextrinas
Liu et al. Bifunctional lipids in tumor vaccines: an outstanding delivery carrier and promising immune stimulator
FR2796955A1 (fr) Cyclodextrines monosubstitues a persubstitues par des groupements fluoroalkyles, leur preparation et leur utilisation
JP2026503538A (ja) ポリオキサゾリン-脂質コンジュゲートを含むナノ粒子による抗原提示細胞のターゲティング